Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
about
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadComparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisForns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis CNonalcoholic fatty liver disease as a multi-systemic diseaseFour-dimensional flow magnetic resonance imaging in cirrhosis.Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageChronic hepatitis C and liver fibrosis.Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and OpinionPrimary biliary cirrhosis: Clinical and laboratory criteria for its diagnosisUltrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoniEvaluation of liver fibrosis: "Something old, something new…"Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) in Diagnosis of Liver Fibrosis among Egyptian Patients with Chronic HCV InfectionPrinciples and clinical application of ultrasound elastography for diffuse liver disease.Invasive and non-invasive diagnosis of cirrhosis and portal hypertensionNon-invasive markers for hepatic fibrosisNon-invasive assessment of liver fibrosis in chronic hepatitis C.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Meta-analyses of FibroTest diagnostic value in chronic liver disease.Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.A novel system for predicting liver histopathology in patients with chronic hepatitis BSequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis BThe role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.Non-invasive serum fibrosis markers: A study in chronic hepatitis.Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease.A comparative study of non-invasive methods for fibrosis assessment in chronic HCV infectionMarkers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CNoninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.How should we manage patients with non-alcoholic fatty liver disease in 2007?FibroMAX: towards a new universal biomarker of liver disease?Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and realityMagnetic resonance imaging of hepatic fibrosis: emerging clinical applications.Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 DiabetesBiochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis.Non-alcoholic steatohepatitis with normal aminotransferase values.Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
P2860
Q21144283-B43129A1-4E4A-40A5-85DC-08D215190197Q21261905-DA16B57A-B494-4DB0-B1A4-B8408D9D045EQ24188065-3B6E928D-7205-4EFA-A118-B0025980DE6EQ26749290-538A93D6-49C2-4BE5-98DB-3DD917A227B6Q26769606-6D9F41AE-EC05-4C98-A1F6-34C7765C280CQ26773289-B7BA68B9-C41B-4133-94A7-7DD1C7F4A426Q26825671-FC09655E-7E2D-4783-9BAB-DF81F48963B6Q26852557-FB17D87A-7302-40E3-A5CB-61DA8DCF0DBDQ26992087-55CB0B66-7BC9-44B9-A817-3772B89BAC71Q27008387-DBD3E64D-803C-4043-B45B-8F055AF5D007Q28068532-005692BB-4214-4B65-A153-03085AFECA42Q30372945-5A48B9BF-81E8-484B-9746-0652DBD7189FQ30434361-C3517377-FCEC-46AD-AEEC-E55B96D7126BQ30439743-819EEF37-F707-4693-9812-06EB630A3024Q30474093-58AABDE4-8660-4DBF-921B-B361EA5CF447Q30474738-8625F05F-9EDC-40AC-807D-AE1C380D661DQ30476922-F27BB712-3CB9-49BC-9AE8-52796C473F07Q33302708-28E82BBD-6E1A-4ED8-8613-03F40525B4B2Q33389189-E808D38A-4284-440F-84A0-06CCDBB16B59Q33621252-5D648CB5-A689-4EDD-8D3F-98673C6EB083Q33787916-05F9A668-31FE-4E75-81A8-BEC36BB7AE2FQ33999294-37F52E1F-892E-45F8-9D2F-22885BF86077Q34532528-44BD92E8-678C-4E4E-B303-B2D63694C39FQ34551475-F6779E0C-A5EF-4AF1-B2F8-C948C498B0B5Q34686484-E468B2A4-C1F5-4083-ACD5-D8C744E8D8EDQ35233535-6FDE61C6-3C72-4DCE-8D3C-574CB5EDD3B9Q35458645-F0A61439-74F1-4A8F-8481-F77F8C9ADB90Q35540294-CA469137-BF74-4994-B47B-1EB5EBE7F36BQ35724652-BB376445-7EF0-4DE5-B9EB-FFEC9A5D2CBAQ35810531-AC309733-71EF-49B7-80B1-65C5D4F97AA2Q36049926-9F0A8D51-F566-40C0-93FF-50494730C9F0Q36848280-68E27E88-25DC-4EF8-BF52-C533F2485592Q36950410-85EEB84C-2FBA-4C46-9B52-DD95DB7D6E1DQ36990696-6F2C23C9-51BA-43E5-8B86-22D4E8CCB663Q37045809-ED4915A2-96CA-46EA-ACC2-107D9C4C8A0AQ37048666-5D59D289-D536-476D-8197-466684C97EAFQ37122292-E0D8D923-4E65-44DA-AF39-3F515BD5F5B1Q37161620-B6D273BD-BDA6-4519-863C-6BDA68F9B26BQ37192623-9D5A8841-F3D5-4847-8274-35CD17444FDBQ37263883-675C68E4-0287-478E-8EA3-01C55909F28E
P2860
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@ast
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@en
type
label
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@ast
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@en
prefLabel
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@ast
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@en
P2860
P356
P1476
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
@en
P2093
Alfredo Alberti
Giada Sebastiani
P2860
P304
P356
10.3748/WJG.V12.I23.3682
P407
P577
2006-06-01T00:00:00Z